…
…
Switzerland
Herz — Switzerland Desk · · 30s summary · 2 min read
Christophe Dessimoz, director of the Swiss Institute of Bioinformatics in Lausanne, published an opinion piece on July 21, 2026 in Le Temps calling for Switzerland to establish itself as the global capital for trustworthy scientific data. He argues that data quality directly determines AI effectiveness: biased or incomplete data produces unreliable results. Switzerland has strong assets according to him—scientific excellence, reliability and international cooperation—to claim this role. Such data serves to understand diseases, monitor the environment and guide policy decisions.
Christophe Dessimoz, director of the Swiss Institute of Bioinformatics (SIB) in Lausanne, published an opinion piece on July 21, 2026 at 3:30 p.m. in Le Temps. It is titled "Switzerland Must Become the Global Capital for Trustworthy Scientific Data".
In this text, Dessimoz argues that the value of artificial intelligence depends directly on the data that feeds it. Incomplete, biased or poor-quality data produces unreliable results. Robust, well-documented and accessible data, by contrast, enable reproducible and trustworthy analyses.
The author highlights the practical uses of scientific data: understanding the evolution of diseases, tracking environmental changes, accelerating discoveries and informing policy decisions.
To support his case, Dessimoz identifies four assets of Switzerland: scientific excellence, quality, reliability and cooperation. He presents them as competitive advantages enabling the country to aspire to this global role.
The opinion piece cites in a sidebar CERN—the European Organization for Nuclear Research, also referred to as the European Laboratory for Particle Physics—as an example of Switzerland's international scientific anchor. Founded in 1954, this organization straddles the Franco-Swiss border between Geneva and neighboring French municipalities, and conducts its research through particle accelerators.
Dessimoz's opinion piece is a strategic appeal. It does not specify a roadmap, concrete measures or institutional actors who could carry this project of a global capital for scientific data.
Furthermore, an automated search for a verified encyclopedic definition of the acronym "SIB" did not return a source matching the Swiss Institute of Bioinformatics. The full designation of the institution is taken directly from the source text cited as reference.
According to Dessimoz, incomplete, biased or poor-quality data produce unreliable results. Robust, well-documented and accessible data, by contrast, enable reproducible and trustworthy analyses.
Dessimoz cites scientific excellence, quality, reliability and international cooperation as the country's main competitive advantages.
They enable understanding the evolution of diseases, tracking environmental changes, accelerating scientific discoveries and informing policy decisions.
No comments yet. Be the first to react.